A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis

.

Source: Amyloid: The Journal of Protein Folding Disorders - May 22, 2023 Category: Biochemistry Authors: Sriram Ravichandran Andrew Hall Matthew Jenner Mamta Garg Bhuvan Kishore Helen Lachmann Julian Gillmore Alexandra Pitchford Jamie B. Oughton Shameem Mahmood Sajitha Sachchithantham Philip Hawkins Sarah Brown Ashutosh Wechalekar Source Type: research